Risk factor
Strong trading liquidity
Profitability factor
Favourable analyst view
About
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries....
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is underpriced on P/E, 'expensive' on EV/EBITDA
Target Price
The average target price of ENOV is 44 and suggests 94% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell